Back to KYMR
Merck & Co., Inc. KYMR Position History
Kymera Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$86.3M
Q3 2026
Peak value
$88.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $60.1M |
| Q1 2026 | $64.3M |
| Q2 2026 | $88.5M |
| Q3 2026 | $86.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $86.3M | 772.2K | — | — |
| Q2 2026 | $88.5M | 772.2K | — | — |
| Q1 2026 | $64.3M | 772.2K | — | — |
| Q4 2025 | $60.1M | 772.2K | — | — |
Other funds holding KYMR
$992.7M
$985.9M
$967.8M
$954.7M
$857.1M
$835.6M